1. WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran
2. Update on Screening Recommendations for Hydroxychloroquine Retinopathy
3. 3Liu XW, Zha QL, He YT. [Comparative study on characteristics of Chinese and Western medicine for treatment of rheumatoid arthritis regarding cartilage erosion related blood biochemical and immunological factors]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27(12):1090-3.
4. DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
5. Ruiz RS, Saatci OA. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients. Ann Ophthalmol. 1991;23(8):290-1.